Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Advanced Proteome Therapeutics Corporation V.APC.H

Alternate Symbol(s):  APTCF

Advanced Proteome Therapeutics Corporation is actively seeking additional funds to advance its core technologies for partnering and other potential revenue streams. It is not engaged in any activity.


TSXV:APC.H - Post by User

Comment by Horn1369on Mar 07, 2019 12:32pm
35 Views
Post# 29456031

RE:What is happening is

RE:What is happening isEvery one knows this is extremelt undervalued. With the news release on Feb 27th buying and holding should be a easy decision. 

"Dr. Dini has conducted a preliminary audit of the company’s IP portfolio and has delivered an initial report that confirms the board’s viewpoint as to the undervaluation of the Company’s technology.

Dr. Dini has concluded that the company has multiple paths to success that should be explored simultaneously, including:

1. Licensing of the technology
2. Co-development of the technology
3. Acquisition of the technology
4. Venture funding and in-house development


The latter two paths had to date not been pursued by the company, and represent more immediate value drivers. Dr. Dini has been engaged for an initial 6-month period and will be compensated for any positive outcome with his list of organizations, which include 5 of the world’s top pharmaceutical companies by market cap. Dr. Dini’s efforts are additive to the Company’s own initiatives and efforts in this regard.



Bullboard Posts